Inactive Instrument

News Viveve Medical Inc Nasdaq

Equities

CA92852W2040

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	CI
2023	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	25/23/25	CI
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	23/23/23	CI
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	18/23/18	AQ
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index	18/23/18	CI
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	18/23/18	MT
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	18/23/18	MT
Top Midday Decliners	18/23/18	MT
Sector Update: Health Care	18/23/18	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	17/23/17	MT
Sector Update: Health Care	17/23/17	MT
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	17/23/17	MT
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	17/23/17	MT
Top Premarket Decliners	17/23/17	MT
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	17/23/17	MT
Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K	17/23/17	PU
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	17/23/17	CI
VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	17/23/17	AQ
Viveve Medical to Seek Strategic Alternatives	17/23/17	CI
VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	15/22/15	AQ
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	15/22/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Viveve Medical Inc Nasdaq

Equities

CA92852W2040

Summary

Filters